Research progress of immunotherapy for advanced head and neck cancer

被引：1

作者：

Sun, Anchi ^{[1
,2
]}

Xing, Zhiwei ^{[1
]}

Lv, Rongrong ^{[1
]}

Niu, Pengyuan ^{[3
]}

Zhao, Bao ^{[1
,4
]}

Ma, Shiyin ^{[1
]}

Li, Hui ^{[1
]}

机构：

[1] Bengbu Med Univ, Dept Otolaryngol, Affiliated Hosp 1, Bengbu 233004, Anhui, Peoples R China

[2] Anhui Engn Technol Res Ctr Biochem Pharmaceut, 2600 Donghai Ave, Bengbu 233030, Anhui, Peoples R China

[3] Bengbu Med Univ, Dept Neurosurg, Affiliated Hosp 1, Bengbu 233004, Anhui, Peoples R China

[4] Hefei Comprehens Natl Sci Ctr, Inst Hlth & Med, Hefei 230071, Peoples R China

来源：

MEDICAL ONCOLOGY | 2024年 / 41卷 / 06期

基金：

中国国家自然科学基金;

关键词：

Head and neck cancer; Immunotherapy; Immune evasion; Combination therapy; Advanced tumors; SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; METASTATIC HEAD; PHASE-II; T-CELLS; RECURRENT; DURVALUMAB; PEMBROLIZUMAB; CETUXIMAB; ANTIGENS;

D O I：

10.1007/s12032-024-02375-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Head and neck cancer accounts for about one-fifth of all malignant tumors, and the incidence is increasing year by year. The overall mortality rate was high and the 5-year survival rate was low. At present, the combination of surgery, radiotherapy, and chemotherapy is the main treatment in clinical practice, but the treatment of recurrent or metastatic advanced head and neck cancer is still a challenge. With the rise of immunotherapy, more and more studies on immune checkpoint inhibitors have been conducted. This review summarizes the mechanism, clinical application and safety of immunotherapy for advanced head and neck cancer.

引用

页数：7

共 45 条

[11] The changing therapeutic landscape of head and neck cancer [J].

Cramer, John D. ;

Burtness, Barbara ;

Quynh Thu Le ;

Ferris, Robert L. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (11) :669-683

[12] THE DETAILED DISTRIBUTION OF MHC CLASS-II ANTIGENS IN NORMAL HUMAN ORGANS [J].

DAAR, AS ;

FUGGLE, SV ;

FABRE, JW ;

TING, A ;

MORRIS, PJ .

TRANSPLANTATION, 1984, 38 (03) :293-298

[13] Cancer immunoediting: from immunosurveillance to tumor escape [J].

Dunn, GP ;

Bruce, AT ;

Ikeda, H ;

Old, LJ ;

Schreiber, RD .

NATURE IMMUNOLOGY, 2002, 3 (11) :991-998

[14] The three Es of cancer immunoediting [J].

Dunn, GP ;

Old, LJ ;

Schreiber, RD .

ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :329-360

[15] New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis [J].

Etxeberria, Inaki ;

Glez-Vaz, Javier ;

Teijeira, Alvaro ;

Melero, Ignacio .

ESMO OPEN, 2019, 4 :e000733

[16] Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer [J].

Ferris, Robert L. ;

Moskovitz, Jessica ;

Kunning, Sheryl ;

Ruffin, Ayana T. ;

Reeder, Carly ;

Ohr, James ;

Gooding, William E. ;

Kim, Seungwon ;

Karlovits, Brian J. ;

Vignali, Dario A. A. ;

Duvvuri, Umamaheswar ;

Johnson, Jonas T. ;

Petro, Daniel ;

Heron, Dwight E. ;

Clump, David A. ;

Bruno, Tullia C. ;

Bauman, Julie E. .

CLINICAL CANCER RESEARCH, 2022, 28 (07) :1335-1344

[17] The PD-1 pathway in tolerance and autoimmunity [J].

Francisco, Loise M. ;

Sage, Peter T. ;

Sharpe, Arlene H. .

IMMUNOLOGICAL REVIEWS, 2010, 236 :219-242

[18] Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects [J].

Grimmig, Tanja ;

Gasser, Martin ;

Moench, Romana ;

Zhu, Lang-Jing ;

Nawalaniec, Karol ;

Callies, Simone ;

Wagner, Martin ;

Polat, Buelent ;

Mothi, Suraj Sarvode ;

Luo, Yueming ;

Ribas, Carmen M. ;

Malafaia, Osvaldo ;

Hsiao, Li-Li ;

Waaga-Gasser, Ana Maria .

ONCOIMMUNOLOGY, 2019, 8 (12)

[19] Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651 [J].

Haddad, Robert I. ;

Harrington, Kevin ;

Tahara, Makoto ;

Ferris, Robert L. ;

Gillison, Maura ;

Fayette, Jerome ;

Daste, Amaury ;

Koralewski, Piotr ;

Zurawski, Bogdan ;

Taberna, Miren ;

Saba, Nabil F. ;

Mak, Milena ;

Kawecki, Andrzej ;

Girotto, Gustavo ;

Alvarez Avitia, Miguel Angel ;

Even, Caroline ;

Toledo, Joaquin Gabriel Reinoso ;

Guminski, Alexander ;

Muller-Richter, Urs ;

Kiyota, Naomi ;

Roberts, Mustimbo ;

Khan, Tariq Aziz ;

Miller-Moslin, Karen ;

Wei, Li ;

Argiris, Athanassios .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (12) :2166-+

[20] Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck The Phase 2 CheckMate 714 Randomized Clinical Trial [J].

Harrington, Kevin J. ;

Ferris, Robert L. ;

Gillison, Maura ;

Tahara, Makoto ;

Argiris, Athanasios ;

Fayette, Jerome ;

Schenker, Michael ;

Bratland, Ase ;

Walker, John W. T. ;

Grell, Peter ;

Even, Caroline ;

Chung, Christine H. ;

Redman, Rebecca ;

Coutte, Alexandre ;

Salas, Sebastien ;

Grant, Cliona ;

de Azevedo, Sergio ;

Soulieres, Denis ;

Hansen, Aaron R. ;

Wei, Li ;

Khan, Tariq Aziz ;

Miller-Moslin, Karen ;

Roberts, Mustimbo ;

Haddad, Robert .

JAMA ONCOLOGY, 2023, 9 (06) :779-789

← 1 2 3 4 5 →